Sisi Yu

Sisi Yu

Auto-generated profile, based on publicly available information

Sisi Yu

Department of Medical Oncology, Sichuan Clinical Research Center for Cancer, Sichuan Cancer Hospital & Institute, Sichuan Cancer Center, University of Electronic Science and Technology of China, Chengdu, China

Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
12 April 2025 in Genomics, Proteomics & Bioinformatics
Verified
Journal Article
Open access
HLHuaichao Luo
Huaichao Luo
CWChangchun Wu
Changchun Wu
SYSisi Yu
Sisi Yu
HRHanxiao Ren
Hanxiao Ren
XYXing Yin
Xing Yin
DWDongsheng Wang
Dongsheng Wang
Platelets are vital in many pathophysiological processes, yet there is a lack of a comprehensive resource dedicated specifically to platelet research. To fill this gap, we have developed PlateletBase, a knowledge base aimed at enhancing the understanding and study of platelets and related diseases. Our team retrieved information from various public databases, specifically extracting and analyzing RNA sequencing (RNA-seq) data from 3711 samples across 41 different conditions available on the National Center for Biotechnology Information (NCBI). PlateletBase offers six analytical and visualization tools, enabling users to perform gene similarity analysis, pair correlation, multi-correlation, expression ranking, clinical information association, and gene annotation for platelets. The current version of PlateletBase includes 10,278 genomic entries, 31,758 transcriptomic entries, 4869 proteomic entries, 2614 omics knowledge entries, 1833 drugs, 97 platelet resources, 438 diseases/traits, and six analysis modules. Each entry has been carefully curated and supported by experimental evidence. Additionally, PlateletBase features a user-friendly interface designed for efficient querying, manipulation, browsing, visualization, and analysis of detailed platelet protein and gene information. The case studies on gray platelet syndrome and angina pectoris demonstrate that PlateletBase is a suitable tool for identifying diagnostic biomarkers and exploring disease mechanisms, thereby advancing research in platelet functionality. PlateletBase is accessible at http://plateletbase.clinlabomics.org.cn/.

28 October 2025 in Cancer Research
Verified
Journal Article
Open access
HLHuaichao Luo
Huaichao Luo
WGWei Guo
Wei Guo
XLXinyu Luan
Xinyu Luan
TYTao Yue
Tao Yue
SYSisi Yu
Sisi Yu
SCShifu Chen
Shifu Chen
Indeterminate pulmonary nodules (IPN) are increasingly detected due to increasing health awareness and widespread lung cancer screening, yet distinguishing benign from malignant nodules remains a critical challenge. Emerging evidence suggests that recognizing cancer-associated immune signatures represents a powerful approach for early-stage cancer detection. This study explored the clinical utility of T-cell receptor (TCR) repertoire analysis in IPN evaluation. By conducting large-scale TCR sequencing (6,059 blood and 988 tumor samples), we established LungTCR (https://www.lungtcr.com/), a comprehensive TCR repertoire database, and proposed a method for the quantitative assessment of tumor-related immune responses. LungTCR was leveraged to develop TCRnodseek plus, a diagnostic model integrating clinical data, CT imaging, and TCR features. A multicenter prospective study (ChiCTR2200055761) involving 1,107 patients with IPN validated the superior diagnostic performance of TCRnodseek plus over existing approaches. Mechanistic analyses revealed that the identified lung cancer–related TCR clones are enriched in non–small cell lung cancer and are predominantly present in malignant nodules and tumor tissues. This study provides a robust TCR database and an advanced diagnostic model, offering a framework for precise IPN differentiation. Significance: Construction of the largest TCR database of lung nodules enabled identification of lung cancer–specific TCR sequences and development of an advanced machine learning model to distinguish benign from malignant pulmonary nodules. This article is part of a special series: Driving Cancer Discoveries with Computational Research, Data Science, and Machine Learning/AI .


15 December 2025
Verified
Other
Open access
HLHuaichao Luo
Huaichao Luo
WGWei Guo
Wei Guo
XLXinyu Luan
Xinyu Luan
TYTao Yue
Tao Yue
SYSisi Yu
Sisi Yu
SCShifu Chen
Shifu Chen
Annotation of lung cancer enriched CDR3-beta sequences

15 December 2025
Verified
Other
Open access
HLHuaichao Luo
Huaichao Luo
WGWei Guo
Wei Guo
XLXinyu Luan
Xinyu Luan
TYTao Yue
Tao Yue
SYSisi Yu
Sisi Yu
SCShifu Chen
Shifu Chen
Model interpretability and lung cancer-enriched TCRs validation

15 December 2025
Verified
Other
Open access
HLHuaichao Luo
Huaichao Luo
WGWei Guo
Wei Guo
XLXinyu Luan
Xinyu Luan
TYTao Yue
Tao Yue
SYSisi Yu
Sisi Yu
SCShifu Chen
Shifu Chen
Clinical and TCR characteristics for patients with indeterminate pulmonary nodules